Back to search

National and Kapodistrian University of Athens

Παθήσεις χοληφόρων: επεμβατική ακτινολογία

Abstract

dc:description

Introduction: Percutaneous metal stenting is an accepted palliative treatment for malignant biliary obstruction. Nevertheless, factors predicting survival are not known. Purpose: To evaluate, the prognostic factors which designate the survival of patients with inoperable malignant obstructive jaundice, who were treated with percutaneous insertion of metallic endoprothesis, as well as to assess the effectiveness of the procedure. Materials and Methods: During a 3-year period, 95 patients with inoperable malignant biliary obstruction were treated with percutaneous placement of metallic stents. Twenty five patients had non-hilar lesions. Seventy patients had hilar lesions classified as Bismuth type I n=18 patients, type II n=31, type III n=15 and type IV n=6 patients. Technical and clinical success rates, complications, and long-term outcome were recorded. Clinical success rates, patency and survival rates were compared in patients treated with complete (n=52) versus partial (n=43) liver parenchyma drainage. Survival was calculated and analyzed for potential predictors like the tumor type, the extent of the disease, the level of obstruction, and the bilirubin levels post-intervention. Results: Stenting was technically successful in all patients (unilateral drainage in 86 patients, bilateral drainage in 9 patients) with an overall significant reduction of the bilirubin levels post intervention (p<0.001), resulting in a clinical success rate of 97.9%. In patients whose bilirubin levels decreased to 0.4-3.9mg/dl survival ranged from 18 to 980 (mean 227.5). In forty five patients whose bilirubin levels were ≥ 4.0mg/dl postprocedural, the survival ranged from 4 to 366 days (mean 101.0). Clinical success rates were similar in patients treated with whole liver drainage versus partial liver drainage. Minor and major complications occurred in 6.3% and 11.6% of patients, respectively. Mean overall primary stent patency was 146.1 days, while restenosis rate was 13.7%. Mean overall secondary stent patency was 166.9 days. Patency rates were similar in patients with complete versus partial liver drainage. Mean overall survival was 167.6 days (SD= 184.3). Survival was similar in complete and partial drainage groups. Serum bilirubin levels post intervention was an independent predictor of survival (p<0,001). A cut-off point in post-stent bilirubin levels of 4 mg/dl dichotomised patients with good versus poor prognosis. Patients' age and Bismuth IV lesions, were also independent survival predictors. Conclusions: Percutaneous metallic biliary stenting provides good palliation of malignant jaundice. Partial liver drainage achieved as good results as complete liver drainage. Serum bilirubin levels less than 4 mg/dl after stenting are the most important independent survival predictors, while increasing age, and Bismuth IV lesions represent dismal prognostic factors.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ptohis, Nikolaos
  • Πτώχης, Νικόλαος

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/22330

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ptohis, Nikolaos; Πτώχης, Νικόλαος. Παθήσεις χοληφόρων: επεμβατική ακτινολογία. National and Kapodistrian University of Athens, 2007. http://hdl.handle.net/10442/hedi/22330